Continuous Femoral Nerve Block With a Tibial Plateau Fracture

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Tibial Plateau Fracture
Interventions
DRUG

bupivacaine

This drug is standard of care. The point of the study is to see if this method will yield better pain scores and improved patient satisfaction vs. non-nerve block. Simply: prospective observation of two standard methods.

Trial Locations (1)

84108

University of Utah, Salt Lake City

All Listed Sponsors
lead

University of Utah

OTHER

NCT02168959 - Continuous Femoral Nerve Block With a Tibial Plateau Fracture | Biotech Hunter | Biotech Hunter